Literature DB >> 9504340

The immune response to Leishmania: mechanisms of parasite control and evasion.

C Bogdan1, M Röllinghoff.   

Abstract

After transmission of Leishmania parasites by sandflies, disease manifestation of the infection requires mechanisms which allow the parasites to replicate in the mammalian host and to resist, at least initially, its innate and acquired antileishmanial defence. Likewise, lifelong persistence of Leishmania parasites, as it occurs even in cases of clinical healing of the infection, points to the existence of strategies which enable the parasite to partially circumvent the protective adaptive immune response of the host. In this review we will discuss the mechanisms which can be invoked to contribute to the initial, as well as long-term, survival of Leishmania parasites in the host organism. These include the passive protection of the parasite against antileishmanial products and the retreat into "safe target cells", the active suppression of the synthesis of reactive oxygen or nitrogen intermediates, the modulation of the host cytokine response, the inhibition of antigen-presentation and T cell-stimulation, and the induction and expansion of counterprotective T helper cells. It is probable that none of these mechanisms alone is sufficient to guarantee the survival of Leishmania, but together they might provide the safe environment which protects the parasite from elimination.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504340     DOI: 10.1016/s0020-7519(97)00169-0

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  73 in total

1.  Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis.

Authors:  S Mukhopadhyay; S Bhattacharyya; R Majhi; T De; K Naskar; S Majumdar; S Roy
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 2.  What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis.

Authors:  Marcus Maurer; Blaise Dondji; Esther von Stebut
Journal:  Med Microbiol Immunol       Date:  2009-04-25       Impact factor: 3.402

3.  Spontaneous recovery of pathogenicity by Leishmania major hsp100-/- alters the immune response in mice.

Authors:  Linda Reiling; Thomas Jacobs; Manfred Kroemer; Iris Gaworski; Sebastian Graefe; Joachim Clos
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

4.  Characterization of the Protein Tyrosine Phosphatase LmPRL-1 Secreted by Leishmania major via the Exosome Pathway.

Authors:  Sabine Leitherer; Joachim Clos; Elisabeth M Liebler-Tenorio; Ulrike Schleicher; Christian Bogdan; Didier Soulat
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

5.  Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies.

Authors:  Ricardo Silvestre; Anabela Cordeiro-da-Silva; Joana Tavares; Denis Sereno; Ali Ouaissi
Journal:  Immunology       Date:  2006-10-09       Impact factor: 7.397

6.  Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production.

Authors:  Geneviève Forget; David J Gregory; Lorie A Whitcombe; Martin Olivier
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

7.  Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease.

Authors:  R G Titus; G K DeKrey; R V Morris; M B Soares
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

8.  Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment.

Authors:  Luiza C Reis; Maria Edilenza F Brito; Marina A Souza; Angela C R Medeiros; Claudio J Silva; Carlos F Luna; Valéria R A Pereira
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

9.  Overexpression of a single Leishmania major gene enhances parasite infectivity in vivo and in vitro.

Authors:  Linda Reiling; Mareike Chrobak; Christel Schmetz; Joachim Clos
Journal:  Mol Microbiol       Date:  2010-03-25       Impact factor: 3.501

10.  Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.

Authors:  Anselmo S Souza; Angela Giudice; Júlia Mb Pereira; Luís H Guimarães; Amelia R de Jesus; Tatiana R de Moura; Mary E Wilson; Edgar M Carvalho; Roque P Almeida
Journal:  BMC Infect Dis       Date:  2010-07-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.